3D InSight™ Liver Disease models are based on 3D InSight™ Human Liver Microtissue technology. They are engineered to incorporate all the primary human liver cells required to recapitulate the disease state, including primary hepatocytes, Kupffer cells and liver endothelial cells. These advanced models are designed for high throughput screening and efficacy testing of drugs for metabolic diseases of the liver, and are ideal for long-term dosing protocols necessary to gauge effectiveness of novel compounds.
Screen and test efficacy of antifibrotic drugs in a powerful 3D Fibrosis model.
Diet-induced Steatosis Model
This model is in the final stages of development and will be available soon.